Efficacy of Lansoprazole in Chronic Post Nasal Drip

PHASE3CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Larynx Disease
Interventions
DRUG

Lansoprazole Tablet

40 mg bid x 16 weeks

PROCEDURE

PH and impedence testing

24 hour ph monitoring

PROCEDURE

manometry

done prior to pH probe to measure length of esophagus

DRUG

lansoprazole

40mg bid

DRUG

placebo

one tablet bid

Trial Locations (1)

37232-5280

Vanderbilt University Medical Center, Vanderbilt Digestive Disease Clinic, TVC, Room 1660, Nashville

All Listed Sponsors
collaborator

TAP Pharmaceutical Products Inc.

INDUSTRY

lead

Vanderbilt University

OTHER

NCT00335283 - Efficacy of Lansoprazole in Chronic Post Nasal Drip | Biotech Hunter | Biotech Hunter